scholarly article | Q13442814 |
P433 | issue | 19 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | fatty acid | Q61476 |
macular degeneration | Q27429789 | ||
eye disease | Q3041498 | ||
P304 | page(s) | 2005 | |
2005-15 | |||
P577 | publication date | 2013-05-15 | |
P1433 | published in | The Journal of the American Medical Association | Q1470970 |
P1476 | title | Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration | |
Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration | |||
Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial | |||
P478 | volume | 309 |
Q64901264 | A Critical Appraisal of National and International Clinical Practice Guidelines Reporting Nutritional Recommendations for Age-Related Macular Degeneration: Are Recommendations Evidence-Based? |
Q52818918 | A Deep Phenotype Association Study Reveals Specific Phenotype Associations with Genetic Variants in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 (AREDS2) Report No. 14. |
Q33740158 | A Review of Current and Future Management of Geographic Atrophy |
Q33914344 | A glimpse at the aging eye. |
Q89752994 | A low glycemic diet protects disease-prone Nrf2-deficient mice against age-related macular degeneration |
Q37417825 | A randomized controlled trial of omega-3 fatty acids in dry eye syndrome |
Q38996375 | A review of the evidence for dietary interventions in preventing or slowing the progression of age-related macular degeneration |
Q92599989 | A review of the putative causal mechanisms associated with lower macular pigment in diabetes mellitus |
Q94468688 | A semi-automated machine-learning based workflow for ellipsoid zone analysis in eyes with macular edema: SCORE2 pilot study |
Q92214955 | A systems biology approach towards understanding and treating non-neovascular age-related macular degeneration |
Q57809996 | A two-year follow-up of oral antioxidant supplementation in primary open-angle glaucoma: an open-label, randomized, controlled trial |
Q41641535 | AMD-like retinopathy associated with intravenous iron. |
Q38636016 | Absolute and estimated values of macular pigment optical density in young and aged Asian participants with or without age-related macular degeneration. |
Q33945202 | Addressing nutritional gaps with multivitamin and mineral supplements |
Q36223020 | Adherence to a Mediterranean diet, genetic susceptibility, and progression to advanced macular degeneration: a prospective cohort study |
Q38214725 | Advances in the management of macular degeneration |
Q92848771 | Age-Related Macular Degeneration and Associated Risk Factors in the Population-Based Study of Health in Pomerania (SHIP-Trend) |
Q26799617 | Age-Related Macular Degeneration: Advances in Management and Diagnosis |
Q26823002 | Age-related Eye Disease Study 2: perspectives, recommendations, and unanswered questions |
Q57299740 | Age-related macular degeneration |
Q51807855 | Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD study. |
Q37068063 | Age-related macular degeneration-clinical review and genetics update |
Q37315838 | Aging is not a disease: distinguishing age-related macular degeneration from aging |
Q38330232 | An Evidence-Based Systematic Review of Lutein by the Natural Standard Research Collaboration |
Q57826003 | Antecedents of Soft Drusen, the Specific Deposits of Age-Related Macular Degeneration, in the Biology of Human Macula |
Q24194251 | Anti-vascular endothelial growth factor for neovascular age-related macular degeneration |
Q92133213 | Anti-vascular endothelial growth factor for neovascular age-related macular degeneration |
Q38653249 | Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. |
Q38169110 | Antioxidants and vision health: facts and fiction |
Q36678494 | Assessment of lutein, zeaxanthin and meso-zeaxanthin concentrations in dietary supplements by chiral high-performance liquid chromatography |
Q31143690 | Association of HDL-related loci with age-related macular degeneration and plasma lutein and zeaxanthin: the Alienor study |
Q48553385 | Association of Mortality with Ocular Diseases and Visual Impairment in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 13. |
Q57141419 | Association of obesity and age-related macular degeneration in Indian population |
Q58691836 | Association of serum lutein and zeaxanthin with quantitative measures of retinal vascular parameters |
Q40047525 | Associations Between Vitamin D Intake and Progression to Incident Advanced Age-Related Macular Degeneration |
Q36617497 | Associations of human retinal very long-chain polyunsaturated fatty acids with dietary lipid biomarkers |
Q55225281 | Attenuation of choroidal neovascularization by dietary intake of ω-3 long-chain polyunsaturated fatty acids and lutein in mice. |
Q37607650 | Beneficial effects of the nutritional supplements on the development of diabetic retinopathy |
Q39014462 | Benefits, Potential Harms, and Optimal Use of Nutritional Supplementation for Preventing Progression of Age-Related Macular Degeneration |
Q34185581 | Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study |
Q53124472 | Birdshot Retinochoroidopathy: Differences in Clinical Characteristics between Patients with Early and Late Age of Onset. |
Q38877436 | Bivariate Analysis of Age-Related Macular Degeneration Progression Using Genetic Risk Scores |
Q42374712 | Bone Marrow-Derived Cell Recruitment to the Neurosensory Retina and Retinal Pigment Epithelial Cell Layer Following Subthreshold Retinal Phototherapy |
Q51758276 | C-Reactive Protein As a Mediator of Complement Activation and Inflammatory Signaling in Age-Related Macular Degeneration. |
Q35679791 | CFH Y402H and ARMS2 A69S Polymorphisms and Oral Supplementation with Docosahexaenoic Acid in Neovascular Age-Related Macular Degeneration Patients: The NAT2 Study |
Q36733416 | Can Xanthophyll-Membrane Interactions Explain Their Selective Presence in the Retina and Brain? |
Q37286511 | Candidate gene study of macular response to supplemental lutein and zeaxanthin |
Q38767261 | Cell-based therapeutic strategies for replacement and preservation in retinal degenerative diseases |
Q64076578 | Cellular Signaling in Müller Glia: Progenitor Cells for Regenerative and Neuroprotective Responses in Pharmacological Models of Retinal Degeneration |
Q37728614 | Central Retinal Enrichment Supplementation Trials (CREST): design and methodology of the CREST randomized controlled trials. |
Q47637461 | Challenges in the Development of Therapy for Dry Age-Related Macular Degeneration |
Q35801527 | Changes in Macular Pigment Optical Density and Serum Lutein Concentration in Japanese Subjects Taking Two Different Lutein Supplements |
Q47097580 | Characterizing the effect of supplements on the phenotype of cultured macrophages from patients with age-related macular degeneration |
Q33758267 | Cholesterol in the retina: the best is yet to come. |
Q34930298 | Clinical characteristics and current treatment of age-related macular degeneration |
Q37044220 | Cognitive Function and Its Relationship with Macular Pigment Optical Density and Serum Concentrations of its Constituent Carotenoids |
Q89845989 | Combination of Lutein and Zeaxanthin, and DHA Regulated Polyunsaturated Fatty Acid Oxidation in H2O2-Stressed Retinal Cells |
Q33849096 | Combined influence of poor health behaviours on the prevalence and 15-year incidence of age-related macular degeneration |
Q38170996 | Common cell biologic and biochemical changes in aging and age-related diseases of the eye: toward new therapeutic approaches to age-related ocular diseases |
Q35827351 | Comparison of Mouse and Human Retinal Pigment Epithelium Gene Expression Profiles: Potential Implications for Age-Related Macular Degeneration |
Q54591303 | Comparison of macular pigment and serum lutein concentration changes between free lutein and lutein esters supplements in Japanese subjects. |
Q41002492 | Comparison of macular pigment optical density in patients with dry and wet age-related macular degeneration |
Q58702202 | Complement System and Age-Related Macular Degeneration: Implications of Gene-Environment Interaction for Preventive and Personalized Medicine |
Q35118257 | Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy. |
Q46022690 | Complement factor H in AMD: Bridging genetic associations and pathobiology. |
Q38614012 | Complement pathway biomarkers and age-related macular degeneration. |
Q90692198 | Correlation between Macular Pigment Optical Density and Neural Thickness and Volume of the Retina |
Q33922277 | Correlations Between Macular, Skin, and Serum Carotenoids |
Q38611218 | Cost-effectiveness of age-related macular degeneration study supplements in the UK: combined trial and real-world outcomes data |
Q33897619 | Critical elevation of international normalized ratio in an elderly woman using a natural health product |
Q26778247 | Current therapeutic developments in atrophic age-related macular degeneration |
Q46372230 | Cytochrome P450 monooxygenase lipid metabolites are significant second messengers in the resolution of choroidal neovascularization |
Q30583016 | Cytochrome P450-generated metabolites derived from ω-3 fatty acids attenuate neovascularization |
Q90663721 | Cytoprotective Effects of Natural Highly Bio-Available Vegetable Derivatives on Human-Derived Retinal Cells |
Q61812842 | Development and Validation of a LC⁻MS/MS-Based Assay for Quantification of Free and Total Omega 3 and 6 Fatty Acids from Human Plasma |
Q64928522 | Dietary Antioxidants, Macular Pigment, and Glaucomatous Neurodegeneration: A Review of the Evidence. |
Q57134980 | Dietary Consumption of Lutein and Zeaxanthin in Panama: A Cross-Sectional Study |
Q92210536 | Dietary Habits, Fatty Acids and Carotenoid Levels Are Associated with Neovascular Age-Related Macular Degeneration in Chinese |
Q39116210 | Dietary Intakes of Eicosapentaenoic Acid and Docosahexaenoic Acid and Risk of Age-Related Macular Degeneration |
Q64890273 | Dietary Patterns and Age-Related Macular Degeneration in Korea: The Korea National Health and Nutrition Examination Survey 2010-2011. |
Q99605502 | Dietary Patterns, Carbohydrates, and Age-Related Eye Diseases |
Q34884403 | Dietary bioactives: establishing a scientific framework for recommended intakes |
Q36728621 | Dietary folate, B vitamins, genetic susceptibility and progression to advanced nonexudative age-related macular degeneration with geographic atrophy: a prospective cohort study |
Q47106416 | Dietary guidance for lutein: consideration for intake recommendations is scientifically supported |
Q64247384 | Dietary intervention in patients with age-related macular degeneration: protocol for a randomised controlled trial |
Q38529695 | Dietary modification and supplementation for the treatment of age-related macular degeneration |
Q36549148 | Dietary n-3 Fatty Acid, α-Tocopherol, Zinc, vitamin D, vitamin C, and β-carotene are Associated with Age-Related Macular Degeneration in Japan |
Q35652661 | Dietary supplement enriched in antioxidants and omega-3 protects from progressive light-induced retinal degeneration |
Q30251418 | Dietary supplements and disease prevention - a global overview. |
Q89480311 | Differential composition of DHA and very-long-chain PUFAs in rod and cone photoreceptors |
Q39167698 | Dissecting microRNA dysregulation in age-related macular degeneration: new targets for eye gene therapy |
Q21284507 | Do nutritional supplements have a role in age macular degeneration prevention? |
Q38253067 | Drugs in Phase II clinical trials for the treatment of age-related macular degeneration |
Q38786743 | Drusen maculopathy: a risk factor for visual deterioration |
Q38789140 | Dry Age-Related Macular Degeneration Pharmacology |
Q35930987 | Dynamic Drusen Remodelling in Participants of the Nutritional AMD Treatment-2 (NAT-2) Randomized Trial |
Q42373141 | Early and intermediate age-related macular degeneration: update and clinical review. |
Q64930030 | Effect of Long-Term Xanthophyll and Anthocyanin Supplementation on Lutein and Zeaxanthin Serum Concentrations and Macular Pigment Optical Density in Postmenopausal Women. |
Q34490891 | Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial |
Q96683775 | Effect of an antioxidant supplement containing high dose lutein and zeaxanthin on macular pigment and skin carotenoid levels |
Q58739721 | Effect of omega 3 fatty acids on C-reactive protein and interleukin-6 in patients with advanced nonsmall cell lung cancer |
Q41845904 | Effect of supplemental lutein and zeaxanthin on serum, macular pigmentation, and visual performance in patients with early age-related macular degeneration |
Q91584129 | Effects of Lutein Supplementation in Japanese Patients with Unilateral Age-Related Macular Degeneration: The Sakai Lutein Study |
Q93055205 | Effects of Macuprev® Supplementation in Age-Related Macular Degeneration: A Double-Blind Randomized Morpho-Functional Study Along 6 Months of Follow-Up |
Q37624757 | Effects of multivitamin supplement on cataract and age-related macular degeneration in a randomized trial of male physicians |
Q64898355 | Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degeneration: Chroma and Spectri Phase 3 Randomized Clinical Trials. |
Q38421723 | Efficacy and Safety of Saffron Supplementation: Current Clinical Findings |
Q34425459 | Efficacy of Multivitamin/mineral Supplementation to Reduce Chronic Disease Risk: A Critical Review of the Evidence from Observational Studies and Randomized Controlled Trials |
Q47124297 | Efficacy of a Fatty Acids Dietary Supplement in a Polyethylene Glycol-Induced Mouse Model of Retinal Degeneration |
Q36738021 | Elevated Fundus Autofluorescence in Monkeys Deficient in Lutein, Zeaxanthin, and Omega-3 Fatty Acids |
Q47128247 | Enhancing the efficacy of AREDS antioxidants in light-induced retinal degeneration |
Q34353014 | European survey on the opinion and use of micronutrition in age-related macular degeneration: 10 years on from the Age-Related Eye Disease Study |
Q37472652 | Evaluating Potential Therapies in a Mouse Model of Focal Retinal Degeneration with Age-related Macular Degeneration (AMD)-Like Lesions |
Q46241948 | Evaluating role of bone marrow-derived stem cells in dry age-related macular degeneration using multifocal electroretinogram and fundus autofluorescence imaging |
Q40048038 | Evaluation of Approaches to Analyzing Continuous Correlated Eye Data When Sample Size Is Small |
Q41677822 | Evaluation of a clinical decision-making aid for nutrition advice in age-related macular degeneration. |
Q36525901 | Evaluation of an oral telomerase activator for early age-related macular degeneration - a pilot study |
Q52559837 | Exploring the Use of Molecular Biomarkers for Precision Medicine in Age-Related Macular Degeneration. |
Q51144972 | Factors influencing self-reported use of antioxidant supplements in patients with age-related macular degeneration. |
Q55492700 | Fatty Acids Dietary Supplements Exert Anti-Inflammatory Action and Limit Ganglion Cell Degeneration in the Retina of the EAE Mouse Model of Multiple Sclerosis. |
Q33452521 | Feasibility of Use of a Mobile Application for Nutrition Assessment Pertinent to Age-Related Macular Degeneration (MANAGER2) |
Q36205759 | Features of Age-Related Macular Degeneration in the General Adults and Their Dependency on Age, Sex, and Smoking: Results from the German KORA Study |
Q28066446 | Fish Consumption and Age-Related Macular Degeneration Incidence: A Meta-Analysis and Systematic Review of Prospective Cohort Studies |
Q34090408 | Five-year incidence, progression, and risk factors for age-related macular degeneration: the age, gene/environment susceptibility study |
Q89440936 | Food groups and risk of age-related macular degeneration: a systematic review with meta-analysis |
Q57297134 | Further Evidence on Efficacy of Diet Supplementation with Fatty Acids in Ocular Pathologies: Insights from the EAE Model of Optic Neuritis |
Q38596855 | Gene-Diet Interactions in Age-Related Macular Degeneration |
Q27013719 | Genetic and environmental underpinnings to age-related ocular diseases |
Q37537304 | Genetic evidence for role of carotenoids in age-related macular degeneration in the Carotenoids in Age-Related Eye Disease Study (CAREDS). |
Q26738526 | Genetics and age-related macular degeneration: a practical review for the clinician |
Q48326680 | Genetics and genetic testing for age-related macular degeneration. |
Q28074640 | Geographic Atrophy and Choroidal Neovascularization in the Same Eye: A Review |
Q35573017 | Gossypol Acetic Acid Prevents Oxidative Stress-Induced Retinal Pigment Epithelial Necrosis by Regulating the FoxO3/Sestrin2 Pathway |
Q30276550 | Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue |
Q36196897 | Gut microbiota influences pathological angiogenesis in obesity-driven choroidal neovascularization |
Q44857437 | HYPERSPECTRAL AUTOFLUORESCENCE IMAGING OF DRUSEN AND RETINAL PIGMENT EPITHELIUM IN DONOR EYES WITH AGE-RELATED MACULAR DEGENERATION. |
Q64229464 | Health Benefits of Polyphenols and Carotenoids in Age-Related Eye Diseases |
Q37654216 | Healthcare experiences of patients with age-related macular degeneration: have things improved? Cross-sectional survey responses of Macular Society members in 2013 compared with 1999. |
Q89715398 | Higher Intake of Polyunsaturated Fatty Acid and Monounsaturated Fatty Acid is Inversely Associated With AMD |
Q98563377 | Home Monitoring of Age-Related Macular Degeneration: Real-World Utility of the ForeseeHome Device for Detection of Neovascularization |
Q91588038 | Human Plasma Metabolomics in Age-Related Macular Degeneration: Meta-Analysis of Two Cohorts |
Q58761997 | Imidazole Compounds for Protecting Choroidal Endothelial Cells from Complement Injury |
Q92244364 | Implantation of Scharioth macula lens in patients with age-related macular degeneration: results of a prospective European multicentre clinical trial |
Q39043636 | Induction of necrotic cell death by oxidative stress in retinal pigment epithelial cells |
Q45354500 | Inflammaging: should this term be suitable for age related macular degeneration too? |
Q35755942 | Inflammatory Mechanisms of Age-related Macular Degeneration |
Q30829406 | Intakes of Lutein, Zeaxanthin, and Other Carotenoids and Age-Related Macular Degeneration During 2 Decades of Prospective Follow-up |
Q33739755 | Intravitreal use of bone marrow mononuclear fraction containing CD34+ stem cells in patients with atrophic age-related macular degeneration |
Q57177518 | Intrinsic and Extrinsic Factors Impacting Absorption, Metabolism, and Health Effects of Dietary Carotenoids |
Q92269896 | Investigating the potential of Zernike polynomials to characterise spatial distribution of macular pigment |
Q44870873 | Involvement of a gut-retina axis in protection against dietary glycemia-induced age-related macular degeneration. |
Q64075478 | Is Grassfed Meat and Dairy Better for Human and Environmental Health? |
Q38192127 | Is age-related macular degeneration a manifestation of systemic disease? New prospects for early intervention and treatment |
Q36468066 | Joint Associations of Diet, Lifestyle, and Genes with Age-Related Macular Degeneration |
Q40703905 | Light, lipids and photoreceptor survival: live or let die? |
Q38915148 | Lipids, oxidized lipids, oxidation-specific epitopes, and Age-related Macular Degeneration |
Q89831192 | Long-term Evolution and Remodeling of Soft Drusen in Rhesus Macaques |
Q92008650 | Lutein across the Lifespan: From Childhood Cognitive Performance to the Aging Eye and Brain |
Q37117609 | Lutein acts via multiple antioxidant pathways in the photo-stressed retina |
Q38901504 | Lutein and Zeaxanthin Isomers in Eye Health and Disease |
Q24185832 | Lutein and zeaxanthin for reducing morbidity and mortality in preterm infants |
Q41111119 | Lutein and zeaxanthin isomers modulates lipid metabolism and the inflammatory state of retina in obesity-induced high-fat diet rodent model. |
Q48364825 | Lutein improves cell viability and reduces Alu RNA accumulation in hydrogen peroxide challenged retinal pigment epithelial cells |
Q30693939 | Lutein, zeaxanthin, and meso-zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease |
Q37673168 | Lutein and Zeaxanthin-Food Sources, Bioavailability and Dietary Variety in Age-Related Macular Degeneration Protection |
Q35075333 | Lycium barbarum polysaccharides protected human retinal pigment epithelial cells against oxidative stress-induced apoptosis |
Q37636009 | Macular Pigment Optical Density and Measures of Macular Function: Test-Retest Variability, Cross-Sectional Correlations, and Findings from the Zeaxanthin Pilot Study of Response to Supplementation (ZEASTRESS-Pilot). |
Q89588604 | Macular Pigment Optical Density in the Korean Population: a Cross Sectional Study |
Q34544965 | Macular carotenoid supplementation improves disability glare performance and dynamics of photostress recovery |
Q41918704 | Macular pigment and its contribution to vision. |
Q39231679 | Macular pigment and macular volume in eyes of patients with cystic fibrosis |
Q28072398 | Macular pigment in retinal health and disease |
Q37229764 | Macular pigment optical density: repeatability, intereye correlation, and effect of ocular dominance |
Q34443359 | Macular response to supplementation with differing xanthophyll formulations in subjects with and without age-related macular degeneration |
Q26776069 | Management of Ocular Diseases Using Lutein and Zeaxanthin: What Have We Learned from Experimental Animal Studies? |
Q26824335 | Management of neovascular age-related macular degeneration: current state-of-the-art care for optimizing visual outcomes and therapies in development |
Q38751193 | Mechanisms of selective delivery of xanthophylls to retinal pigment epithelial cells by human lipoproteins |
Q38606762 | Melissa Officinalis L. Extracts Protect Human Retinal Pigment Epithelial Cells against Oxidative Stress-Induced Apoptosis |
Q34531240 | Mice that produce ApoB100 lipoproteins in the RPE do not develop drusen yet are still a valuable experimental system |
Q91660747 | Microvascular contributions to age-related macular degeneration (AMD): from mechanisms of choriocapillaris aging to novel interventions |
Q35685717 | Modifying Choroidal Neovascularization Development with a Nutritional Supplement in Mice |
Q26860718 | Molecular complexes that direct rhodopsin transport to primary cilia |
Q26995315 | NLRP3 inflammasome: activation and regulation in age-related macular degeneration |
Q38174408 | Nature and nurture- genes and environment- predict onset and progression of macular degeneration. |
Q26749178 | Neuroprotection as a Therapeutic Target for Diabetic Retinopathy |
Q52699533 | New GABA modulators protect photoreceptor cells from light-induced degeneration in mouse models. |
Q26776523 | Nitroxide pharmaceutical development for age-related degeneration and disease |
Q35111445 | Novel Nrf2 activators from microbial transformation products inhibit blood-retinal barrier permeability in rabbits. |
Q36941812 | Nutraceutical with Resveratrol and Omega-3 Fatty Acids Induces Autophagy in ARPE-19 Cells |
Q26821899 | Nutrient Supplementation for Age-related Macular Degeneration, Cataract, and Dry Eye |
Q27015832 | Nutrients for the aging eye |
Q34132062 | Nutrition effects on ocular diseases in the aging eye. |
Q93118085 | Nutrition interventions for healthy ageing across the lifespan: a conference report |
Q38800270 | Nutrition, Genes, and Age-Related Macular Degeneration: What Have We Learned from the Trials? |
Q89687694 | Nutritional Supplements for Age-Related Macular Degeneration |
Q58699164 | Nutritional Value of the Duckweed Species of the Genus (Lemnaceae) as Human Food |
Q37592954 | Nutritional and Lifestyle Interventions for Age-Related Macular Degeneration: A Review |
Q49608613 | Nutritional and smoking advice recalled by patients attending a UK age-related macular degeneration clinic. |
Q33914583 | Nutritional risk factors for age-related macular degeneration. |
Q38317289 | Nutritional supplements in age-related macular degeneration |
Q24186584 | Omega 3 fatty acids for preventing or slowing the progression of age-related macular degeneration |
Q64227433 | Omega-3 and ranibizumab for age-related macular degeneration: A systematic review protocol |
Q55919856 | Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease |
Q89958068 | Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease |
Q90307768 | Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease |
Q58698899 | Omega-3 from Flaxseed Oil Protects Obese Mice Against Diabetic Retinopathy Through GPR120 Receptor |
Q35316532 | Omega-3 supplementation combined with anti-vascular endothelial growth factor lowers vitreal levels of vascular endothelial growth factor in wet age-related macular degeneration |
Q38873518 | One protein, multiple pathologies: multifaceted involvement of amyloid β in neurodegenerative disorders of the brain and retina. |
Q38605292 | Optical Coherence Tomography Predictors of Risk for Progression to Non-Neovascular Atrophic Age-Related Macular Degeneration |
Q96155742 | Optimisation of a Novel Bio-Substrate as a Treatment for Atrophic Age-Related Macular Degeneration |
Q37338182 | Overall skin tone and skin-lightening-improving effects with oral supplementation of lutein and zeaxanthin isomers: a double-blind, placebo-controlled clinical trial |
Q37708674 | Oxidative stress and its downstream signaling in aging eyes. |
Q46248374 | Oxidative stress and reactive oxygen species: a review of their role in ocular disease |
Q46824949 | Oxidative stress in dry age-related macular degeneration and exfoliation syndrome |
Q36890365 | Perspective: A Critical Look at the Ancillary Age-Related Eye Disease Study 2: Nutrition and Cognitive Function Results in Older Individuals with Age-Related Macular Degeneration |
Q38510019 | Pharmacogenetics and nutritional supplementation in age-related macular degeneration |
Q38551646 | Photo-damage, photo-protection and age-related macular degeneration. |
Q38921719 | Plasma long-chain omega-3 polyunsaturated fatty acids and macular pigment in subjects with family history of age-related macular degeneration: the Limpia Study |
Q40396176 | Precursors of age-related macular degeneration: associations with vitamin A and interaction with CFHY402H in the Inter99 Eye Study |
Q99239361 | Predicting risk of late age-related macular degeneration using deep learning |
Q33845330 | Press releases issued by supplements industry organisations and non-industry organisations in response to publication of clinical research findings: a case-control study. |
Q35899608 | Prevalence of age-related macular degeneration in the Republic of Ireland. |
Q34395891 | Proof of concept, randomized, placebo-controlled study of the effect of simvastatin on the course of age-related macular degeneration |
Q88007907 | Prophylactic laser in age-related macular degeneration: the past, the present and the future |
Q59798752 | Protective Effects of Extracts on UVB-Induced Damage in Human Retinal Pigment Epithelial Cells Accompanied by Attenuating ROS and DNA Damage |
Q55646884 | Proteomics of Human Retinal Pigment Epithelium (RPE) Cells. |
Q39148545 | Putative protective role of lutein and zeaxanthin in diabetic retinopathy |
Q61798257 | Quantification of Lutein + Zeaxanthin Presence in Human Placenta and Correlations with Blood Levels and Maternal Dietary Intake |
Q35865877 | REPRODUCIBILITY OF MACULAR PIGMENT OPTICAL DENSITY MEASUREMENT BY TWO-WAVELENGTH AUTOFLUORESCENCE IN A CLINICAL SETTING. |
Q27693234 | RPE necroptosis in response to oxidative stress and in AMD |
Q37570185 | Randomized trial of a home monitoring system for early detection of choroidal neovascularization home monitoring of the Eye (HOME) study |
Q38528148 | Ranibizumab and aflibercept for the treatment of wet age-related macular degeneration |
Q36377333 | Recent advances in the management of dry age-related macular degeneration: A review |
Q41532061 | Recent developments in age-related macular degeneration: a review. |
Q28088816 | Recent developments in the management of dry age-related macular degeneration |
Q26751293 | Regulation of signaling events involved in the pathophysiology of neovascular AMD |
Q90462769 | Resvega Alleviates Hydroquinone-Induced Oxidative Stress in ARPE-19 Cells |
Q38749961 | Retinal disease in the C3 glomerulopathies and the risk of impaired vision. |
Q37164303 | Retinal pigment epithelial cell necroptosis in response to sodium iodate |
Q48178677 | Retinal pigment epithelium in the pathogenesis of age-related macular degeneration and photobiomodulation as a potential therapy? |
Q39262744 | Rheopheresis in vascular diseases |
Q89888023 | Risk factors for progression of age-related macular degeneration |
Q52326632 | Rod-Mediated Dark Adaptation and Macular Pigment Optical Density in Older Adults with Normal Maculas. |
Q37298565 | Role of antioxidant enzymes and small molecular weight antioxidants in the pathogenesis of age-related macular degeneration (AMD) |
Q28245638 | Role of lutein and zeaxanthin in visual and cognitive function throughout the lifespan |
Q38211245 | Saffron and retina: neuroprotection and pharmacokinetics. |
Q57808075 | Saffron therapy for the treatment of mild/moderate age-related macular degeneration: a randomised clinical trial |
Q36257030 | Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3 |
Q92751432 | Serum 25-Hydroxyvitamin D Concentrations and Incidence of Age-Related Macular Degeneration: The Atherosclerosis Risk in Communities Study |
Q93088623 | Skin Carotenoid Index in a large Japanese population sample |
Q34394380 | Smoking and age-related macular degeneration: review and update |
Q35230959 | Smoking, antioxidant supplementation and dietary intakes among older adults with age-related macular degeneration over 10 years |
Q38975097 | Structural and molecular changes in the aging choroid: implications for age-related macular degeneration |
Q36401339 | Suboptimal Plasma Long Chain n-3 Concentrations are Common among Adults in the United States, NHANES 2003-2004. |
Q92816070 | Suppression of AMD-Like Pathology by Mitochondria-Targeted Antioxidant SkQ1 Is Associated with a Decrease in the Accumulation of Amyloid β and in mTOR Activity |
Q34476425 | Sustained supplementation and monitored response with differing carotenoid formulations in early age-related macular degeneration |
Q36586130 | Synthesis of docosahexaenoic acid from eicosapentaenoic acid in retina neurons protects photoreceptors from oxidative stress |
Q93157135 | Systematic review of the appropriateness of eye care delivery in eye care practice |
Q36123333 | Systemic confounders affecting serum measurements of omega-3 and -6 polyunsaturated fatty acids in patients with retinal disease. |
Q39092535 | The Age-Related Eye Disease 2 Study: Micronutrients in the Treatment of Macular Degeneration |
Q35716443 | The Clinical Effectiveness and Cost-Effectiveness of Screening for Age-Related Macular Degeneration in Japan: A Markov Modeling Study |
Q93023744 | The Common Antidiabetic Drug Metformin Reduces Odds of Developing Age-Related Macular Degeneration |
Q35596762 | The Effect of BCMO1 Gene Variants on Macular Pigment Optical Density in Young Healthy Caucasians. |
Q58722677 | The Effect of Lutein on Eye and Extra-Eye Health |
Q92221622 | The Effects of Lutein and Zeaxanthin Supplementation on Brain Morphology in Older Adults: A Randomized, Controlled Trial |
Q55224872 | The Evolving Role of Multivitamin/Multimineral Supplement Use among Adults in the Age of Personalized Nutrition. |
Q38692816 | The Pharmacological Effects of Lutein and Zeaxanthin on Visual Disorders and Cognition Diseases. |
Q26769895 | The Photobiology of Lutein and Zeaxanthin in the Eye |
Q50103461 | The Role of Diet in Glaucoma: A Review of the Current Evidence. |
Q58611705 | The Role of Diet, Micronutrients and the Gut Microbiota in Age-Related Macular Degeneration: New Perspectives from the Gut⁻Retina Axis |
Q92982650 | The Role of Fish Oil in Inflammatory Eye Diseases |
Q45975184 | The Role of Mitochondria in AMD: Current Knowledge and Future Applications. |
Q61806326 | The Role of Nutrients in Reducing the Risk for Noncommunicable Diseases during Aging |
Q37406856 | The Royal College of Ophthalmologists Guidelines on AMD: Executive Summary |
Q26749297 | The Treatment Paradigm for the Implantable Miniature Telescope |
Q92354128 | The cGAS/STING pathway: a sensor of senescence-associated DNA damage and trigger of inflammation in early age-related macular degeneration |
Q35133394 | The effect of modified eggs and an egg-yolk based beverage on serum lutein and zeaxanthin concentrations and macular pigment optical density: results from a randomized trial |
Q37639903 | The evidence informing the surgeon's selection of intraocular lens on the basis of light transmittance properties. |
Q57186574 | The impact of lipids, lipid oxidation, and inflammation on AMD, and the potential role of miRNAs on lipid metabolism in the RPE |
Q39197341 | The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD. |
Q38724013 | The influence of substrate modulus on retinal pigment epithelial cells |
Q36111784 | The marine n-3 PUFA DHA evokes cytoprotection against oxidative stress and protein misfolding by inducing autophagy and NFE2L2 in human retinal pigment epithelial cells |
Q35895835 | The novel triterpenoid RTA 408 protects human retinal pigment epithelial cells against H2O2-induced cell injury via NF-E2-related factor 2 (Nrf2) activation |
Q35106624 | The relationship between BCMO1 gene variants and macular pigment optical density in persons with and without age-related macular degeneration |
Q33914613 | The relationship of major American dietary patterns to age-related macular degeneration |
Q38209275 | The role of proteases and inflammatory molecules in triggering neovascular age-related macular degeneration: basic science to clinical relevance |
Q37646779 | The role of the complement system in age-related macular degeneration |
Q35465063 | The self-reported clinical practice behaviors of Australian optometrists as related to smoking, diet and nutritional supplementation |
Q28085495 | The stereotypical molecular cascade in neovascular age-related macular degeneration: the role of dynamic reciprocity |
Q40775624 | The value of multifocal electroretinography to predict progressive visual acuity loss in early AMD. |
Q38978374 | Tolerability in the elderly population of high-dose alpha lipoic acid: a potential antioxidant therapy for the eye. |
Q89455914 | Trapa bispinosa Roxb. and lutein ameliorate cataract in type 1 diabetic rats |
Q88878935 | Treatment of Geographic Atrophy with Intravitreal Sirolimus: The Age-Related Eye Disease Study 2 Ancillary Study |
Q37304930 | Tropical bat as mammalian model for skin carotenoid metabolism |
Q26767098 | Update on Clinical Trials in Dry Age-related Macular Degeneration |
Q34366170 | Update on current and future novel therapies for dry age-related macular degeneration |
Q30843382 | Using current data to define new approach in age related macular degeneration: need to accelerate translational research |
Q35112300 | Verification of Meso-Zeaxanthin in Fish. |
Q33717538 | Visual acuity after cataract surgery in patients with age-related macular degeneration: age-related eye disease study 2 report number 5. |
Q34325624 | Visual function assessment in simulated real-life situations in patients with age-related macular degeneration compared to normal subjects. |
Q37715254 | Visualization of Dietary Patterns and Their Associations With Age-Related Macular Degeneration |
Q36866107 | Vitamin A-aldehyde adducts: AMD risk and targeted therapeutics |
Q47100212 | Vitamin D and Age-Related Macular Degeneration |
Q35476986 | Vitamin D deficiency in neovascular versus nonneovascular age-related macular degeneration |
Q37557154 | Why fish oil fails: a comprehensive 21st century lipids-based physiologic analysis |
Q45072584 | Xanthophylls lutein and zeaxanthin modify gene expression and induce synthesis of hyaluronan in keratinocyte model of human skin |
Q37261208 | Zeaxanthin Induces Apoptosis in Human Uveal Melanoma Cells through Bcl-2 Family Proteins and Intrinsic Apoptosis Pathway |
Q41843418 | Zeaxanthin inhibits hypoxia-induced VEGF secretion by RPE cells through decreased protein levels of hypoxia-inducible factors-1α. |
Q46531483 | Zeaxanthin-based dietary supplement and topical serum improve hydration and reduce wrinkle count in female subjects |
Q34506404 | Zinc supplementation inhibits complement activation in age-related macular degeneration |
Q86603541 | [Supplements in age-related macular degeneration: recommendations by the German Ophthalmological Society, the German Retina Society and the German Professional Association of Ophthalmologists--October 2014] |
Q33897623 | Élévation critique du rapport normalisé international chez une femme de 89 ans qui consomme un produit de santé naturel |
Search more.